Mar 18, 2024 · Reteplase is used to improve heart function and prevent congestive heart failure or death in people who have had a heart attack (acute myocardial infarction). Reteplase may also …

Reteplase is a recombinant non-glycosylated form of human tissue plasminogen activator, which has been modified to contain 357 of the 527 amino acids of the original protein. It is produced …

Reteplase is the r-PA (recombinant plasminogen activator) with nonglycosylated deletion mutant of wild-type tissue plasminogen activator (tPA); has less high-affinity fibrin binding, longer...

Jun 13, 2005 · Reteplase is a purified form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli.

Reteplase is a modified nonglycosylated recombinant form of tPA used to dissolve intracoronary emboli, lysis of acute pulmonary emboli, and handling of myocardial infarction. This protein …

Mar 18, 2024 · Detailed Reteplase dosage information for adults. Includes dosages for Myocardial Infarction; plus renal, liver and dialysis adjustments.

Reteplase is used to treat heart attacks by dissolving blood clots that have formed in the blood vessels of the heart. This medicine is used immediately after symptoms of a heart attack occur …